{"task_id": "6fbec16234f573dc", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 283/464)", "text": "r Science\u00feBusiness Media, LLC 2006, 2007, 2011\n273\n\n--- Page 295 ---\nCLINICAL FEATURES (CONT\u2019D)\nSens\nSpc\nLR+\nLR\nRecent joint surgery\n24%\n96%\n6.9\n0.78\nHip/knee prosthesis\n35%\n89%\n3.1\nSkin infection\n32%\n88%\n2.8\n0.73\nHIV infection\n79%\n50%\n1.7\n0.47\nJoint pain\n85%\nJoint edema\n78%\nFever\n57%\nSweats\n27%\nRigors\n19%\nPhysical\nFever\n46%\n31%\n0.67\n1.7\nInvestigations\nElevated WBC\n90%\n36%\n1.4\n0.28\nElevated ESR\n95%\n29%\n1.3\n0.17\nElevated CRP\n77%\n53%\n1.6\n0.44\nSynovial fluid analysis\nWBC >100,000/mL\n29%\n99%\n28\n0.71\nWBC >50,000/mL\n62%\n92%\n7.7\n0.42\nWBC >25,000/mL\n77%\n73%\n2.9\n0.32\nPMN \u000490%\n73%\n79%\n3.4\n0.34\nAPPROACH\n\u2018\u2018when evaluating a patient with a\npainful, peripheral, swollen joint, the underlying\npathology of a monoarthritis may be difficult to\ndiagnose by clinical history and examination alone\ndue to nonspecific symptoms and signs. Identifi\nable risk factors and arthrocentesis are most helpful\nin predicting septic arthritis. In particular, synovial\nWBC count and percentage of polymorphonuclear\ncells provide the best utility in identifying septic\narthritis while waiting for Gram stain and culture\ntest results. There is no evidence that a patient\u2019s\nsymptoms or the physical examination are useful\nfor predicting non gonococcal bacterial arthritis\u2019\u2019\nJAMA 2007 297:13\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, uric acid, ANA, RF,\nESR, CRP, INR, PTT\n\u0002\nIMAGING\njoint XR (chondrocalcinosis in pseu\ndogout (the presence of crystals does not rule\nout sepsis)\n\u0002\nARTHROCENTESIS\nw3Cw (Cell count with diff,\nCulture and Gram stain, Crystal)\nSPECIAL\n\u0002\nINFECTIOUS\nWORKUP\nurethral/rectal\nswabs,\nblood C&S\nDIAGNOSTIC ISSUES\nGOLDEN RULE\npatients with monoarthritis have\nseptic arthritis until proven otherwise. Joint infection\nDIAGNOSTIC ISSUES (CONT\u2019D)\nis a rheumatologic emergency as permanent damage\ncan occur. Presence of crystal does not rule out\ninfection. In up to 75% of patients with septic arthri\ntis, a focus of infection may be found\nARTHROCENTESIS FLUID ANALYSIS\nNormal\nNon\ninfectious Infectious\nSeptic\nWBC\n(/mm3)\n<200\n200 2000 2000 50,000 >50,000\nPMNs\n<25% <25%\n25 50%\n>50%\nJOINT ASPIRATIONS/INJECTIONS\nfor diagnostic\nand sometimes therapeutic reasons. Absolute contra\nindication is infection overlying site of injection. Rela\ntive contraindications include significant hemostasis\ndefects and bacteremia (NEJM 2006 354:e19)\n\u0002\nKNEE\nflex 10 158, enter either medially or later\nally immediately beneath the undersurface of the\npatella slightly above midway\n\u0002\nANKLE\nfoot perpendicular to leg, medial approach\nimmediately medial to the extensor hallucis longus\ntendon. Lateral approach just distal to fibula\n\u0002\nWRISTS\nflex slightly. Medial approach at dorsal\nsurface between the distal ulna and the carpal\nbones. Lateral approach at dorsum just distal to\nthe end of the radius, between the extensor ten\ndons of the thumb\n\u0002\nADVERSE\nEFFECTS\nOF\nASPIRATIONS/INJECTIONS\nhypersensitivity to anesthetic, pain, infection, ten\ndon rupture, subcutaneous atrophy, post injection\nflare, systemic steroid absorption, hemorrhage,\nsteroid arthropathy\nMANAGEMENT\nREMEMBER TO ALWAYS ASPIRATE BEFORE\nPROCEEDING TO TREATMENT\nSYMPTOM CONTROL\nNSAIDs/opioids for pain\nTREAT UNDERLYING CAUSE\nempiric (if not at\nrisk for sexually transmitted disease, nafcillin 2 g IV\nq4h or vancomycin 1 g IV q12h, plus ceftriaxone 2 g IV\nq24h or cefotaxime 2 g IV q8h. If at risk of sexually\ntransmitted disease, nafcillin 2 g IV q4h for Gram\npositive organisms on Gram stain; otherwise, give\nceftriaxone 2 g IV q24h or cefotaxime 2 g IV q8h\nif organisms not identifiable yet). Gonococcal\n(ceftriaxone 1 g IV q24h). Lyme arthritis (amoxicillin\n500 mg PO QID, doxycycline 100 mg PO BID, ceftriax\none 2 g IV daily, cefotaxime 3 g IV BID \u00054 6 weeks).\nTherapeutic\narthrocentesis.\nArthroscopic\nor\nsurgical drainage (if joint inaccessible to needle\ndrainage, organism resistant to antibiotics, or no\nclinical response in 3 4 days)\n274\nSeptic Arthritis", "text_length": 3904, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 283/464)", "type": "chunk", "chunk_index": 282, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.634654", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.635550", "status": "complete", "chunks_added": 3}